These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31953389)

  • 1. The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD.
    Sun Q; Li X; Perez LM; Shi W; Zhang Y; Sacchettini JC
    Nat Commun; 2020 Jan; 11(1):339. PubMed ID: 31953389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.
    Gopal P; Tasneen R; Yee M; Lanoix JP; Sarathy J; Rasic G; Li L; Dartois V; Nuermberger E; Dick T
    ACS Infect Dis; 2017 Jul; 3(7):492-501. PubMed ID: 28271875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrazinamide triggers degradation of its target aspartate decarboxylase.
    Gopal P; Sarathy JP; Yee M; Ragunathan P; Shin J; Bhushan S; Zhu J; Akopian T; Kandror O; Lim TK; Gengenbacher M; Lin Q; Rubin EJ; Grüber G; Dick T
    Nat Commun; 2020 Apr; 11(1):1661. PubMed ID: 32245967
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Ragunathan P; Cole M; Latka C; Aragaw WW; Hegde P; Shin J; Subramanian Manimekalai MS; Rishikesan S; Aldrich CC; Dick T; Grüber G
    ACS Chem Biol; 2021 Jun; 16(6):1030-1039. PubMed ID: 33984234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Novel Mutations in LprG (
    Shi W; Chen J; Zhang S; Zhang W; Zhang Y
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
    Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
    Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
    Zhang Y; Zhang J; Cui P; Zhang Y; Zhang W
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
    BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missense Mutations in the Unfoldase ClpC1 of the Caseinolytic Protease Complex Are Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis.
    Yee M; Gopal P; Dick T
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD.
    Gopal P; Nartey W; Ragunathan P; Sarathy J; Kaya F; Yee M; Setzer C; Manimekalai MSS; Dartois V; Grüber G; Dick T
    ACS Infect Dis; 2017 Nov; 3(11):807-819. PubMed ID: 28991455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
    Rajendran V; Sethumadhavan R
    J Biomol Struct Dyn; 2014; 32(2):209-21. PubMed ID: 23383724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.
    Zhang Y; Scorpio A; Nikaido H; Sun Z
    J Bacteriol; 1999 Apr; 181(7):2044-9. PubMed ID: 10094680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.
    Rodrigues Vde F; Telles MA; Ribeiro MO; Cafrune PI; Rossetti ML; Zaha A
    Antimicrob Agents Chemother; 2005 Jan; 49(1):444-6. PubMed ID: 15616332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agents.
    Hegde PV; Aragaw WW; Cole MS; Jachak G; Ragunathan P; Sharma S; Harikishore A; Grüber G; Dick T; Aldrich CC
    Bioorg Med Chem; 2022 Nov; 74():117046. PubMed ID: 36228522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis.
    Gopal P; Yee M; Sarathy J; Low JL; Sarathy JP; Kaya F; Dartois V; Gengenbacher M; Dick T
    ACS Infect Dis; 2016 Sep; 2(9):616-626. PubMed ID: 27759369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular principles behind pyrazinamide resistance due to mutations in panD gene in Mycobacterium tuberculosis.
    Pandey B; Grover S; Tyagi C; Goyal S; Jamal S; Singh A; Kaur J; Grover A
    Gene; 2016 Apr; 581(1):31-42. PubMed ID: 26784657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and Mechanistic Insights into
    Saw WG; Leow CY; Harikishore A; Shin J; Cole MS; Aragaw WW; Ragunathan P; Hegde P; Aldrich CC; Dick T; Grüber G
    ACS Infect Dis; 2022 Jul; 8(7):1324-1335. PubMed ID: 35731701
    [No Abstract]   [Full Text] [Related]  

  • 18. A simplified pyrazinamidase test for pyrazinamide drug susceptibility in Mycobacterium tuberculosis.
    Aono A; Chikamatsu K; Yamada H; Igarashi Y; Murase Y; Takaki A; Mitarai S
    J Microbiol Methods; 2018 Nov; 154():52-54. PubMed ID: 30316980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.
    Zimic M; Sheen P; Quiliano M; Gutierrez A; Gilman RH
    Infect Genet Evol; 2010 Mar; 10(2):346-9. PubMed ID: 19963078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages.
    Pires D; Valente E; Simões MF; Carmo N; Testa B; Constantino L; Anes E
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7693-9. PubMed ID: 26438493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.